| Literature DB >> 24291122 |
Ramcés Falfán-Valencia1, Angel Camarena1, César Landa Pineda1, Martha Montaño1, Armida Juárez1, Ivette Buendía-Roldán1, Gloria Pérez-Rubio1, Juan Manuel Reséndiz-Hernández1, Ignacio Páramo1, Anita Vega1, Julio Granados2, Joaquín Zúñiga3, Moisés Selman4.
Abstract
Hypersensitivity Pneumonitis (HP) is a lung inflammatory disorder caused by inhalation of organic particles by a susceptible host. Since only a small proportion of individuals exposed to HP-related antigens develop the disease, a genetic predisposition is largely suspected. However, studies regarding genetic susceptibility in this disease are scanty. We have previously found evidence supporting increased risk associated to the major histocompatibility complex (MHC) in sporadic HP. In the present study, we conducted a family-based research that includes nine multicase families with at least two related HP patients (RHP). We evaluated 19 RHP individuals, 25 additional healthy first-degree relatives (REA) and 246 healthy unrelated individuals (HUI). HLA class II typing (DRB1/3/4/5, DQA1, DQB1, DPA1, DPB1, DMA and DMB), and -863, -308 and -238 polymorphisms in the promoter region of TNF-α were performed by PCR based methods. We identified an increased frequency of HLA-DRB1*04:07, DRB1*04:05, DRB1*11:01 and DRB1*13:01 alleles in RHP individuals compared to healthy controls (p < 0.05). A significant higher frequency of DRB1*04:07-DQB1*03:02, DRB1*04:05-DQB1*03:02, and DRB1*04:03-DQB1*03:02 haplotypes was also detected in the group of patients. Likewise, TNF-238 GG genotype was more frequent in the RHP group as compared to REA (p = 0.01, OR = 7.2). Finally, the combination of HLA-DRB1*04 alleles and TNF-238 GG was significantly increased in the RHP group (p = 0.01, OR = 6.93). These findings indicate that genes located within the MHC region confer susceptibility to familial HP in Mexicans.Entities:
Keywords: Familial HP; Genetic susceptibility; HLA polymorphisms; Hypersensitivity pneumonitis; MHC genes; TNF promoter polymorphisms
Mesh:
Substances:
Year: 2013 PMID: 24291122 DOI: 10.1016/j.rmed.2013.11.004
Source DB: PubMed Journal: Respir Med ISSN: 0954-6111 Impact factor: 3.415